Publication: Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia: Towards a Medicine Policy to Support Vision 2030
Date
2020
ISSN
Published
2020
Author(s)
Alghaith, Taghred
Almoteiry, Khalid
Alamri, Adwa
Alluhidan, Mohammed
Alharf, Adel
Al-Hammad, Bander
Aliafali, Ibrahim
Pisani, Elizabeth
Abstract
This document presents the major issues
that were discussed in the process of working towards the
development of a new medicines policy in Saudi Arabia,
examining current national practice in light of
international practices and experiences. The document is
designed to foster discussion and help inform the
development of a new national medicine policy. A detailed
accounting of the evidence informing policy choices to be
highlighted in an updated medicine policy are presented in
Part I of this discussion paper; a proposed new National
Medicine Policy itself is presented in Part ll. A new
Medicine policy, once finalized and approved, will need to
be implemented in a highly dynamic environment and must
therefore allow for flexibility. It will need to be followed
by the implementation of regulations, closely monitored, and
adapted as necessary over time.
Citation
“Alghaith, Taghred; Almoteiry, Khalid; Alamri, Adwa; Alluhidan, Mohammed; Alharf, Adel; Al-Hammad, Bander; Aliafali, Ibrahim; Seiter, Andreas; Pisani, Elizabeth; Herbst, Christopher H.; El-Saharty, Sameh; Alazemi, Nahar. 2020. Strengthening the Pharmaceutical System in the Kingdom of Saudi Arabia : Towards a Medicine Policy to Support Vision 2030. Health, Nutrition and Population Discussion Paper;. © World Bank, Washington, DC. http://openknowledge.worldbank.org/handle/10986/35846 License: CC BY 3.0 IGO.”